Fossil to be added to S&P 500; Medco Health deleted on date TBA S&P 500 constituent Express Scripts (ESRX) is acquiring Medco Health Solutions (MHS) in a deal expected to be completed soon pending final approvals.
News For FOSL;MHS;ESRX From The Last 14 Days
Check below for free stories on FOSL;MHS;ESRX the last two weeks.
Express Scripts' TriCare contract renewal removes an overhang, says UBS UBS said Express Scripts successful renewal of the TriCare/Department of Defense PBM contract removes an overhang and should contribute 25c-30c to 2014 earnings. The firm expects shares to react positively and reiterates its Buy rating and $72 price target.
Express Scripts TRICARE contract removes key overhang, says Citigroup Citigroup believes the Express Scripts retaining the Department of Defense's TRICARE Pharmacy Program contract removes a key overhang on the stock and validates the company's business model. Citi reiterates a Buy rating on Express Scripts with a $92 price target.